晚期三阴性乳腺癌TYMS基因表达及与化疗疗效相关研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

郑州市科技攻关计划(20130532)


A study about the relationship between TYMS gene expression and chemotherapeutic efficacy in advanced triplenegative breast cancer patients
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    【摘要】 目的 探讨胸苷酸合成酶(TYMS)基因表达与晚期三阴性乳腺癌化疗疗效的关系。方法回顾性分析晚期三阴女性乳癌患者97例,检测患者肿瘤标本TYMS mRNA表达量,明确基因表达与临床特征及化疗疗效的关系。结果 TYMS mRNA表达水平高低与患者的年龄、月经状态、组织学分级、转移部位、Ki67增殖指数及PS评分无明显相关性,TYMS表达水平与氟尿嘧啶类疗效关系密切,低表达者疗效更好,差异有统计学意义(P<005)。结论TYMS基因有望成为晚期三阴性乳腺癌化疗疗效的预测基因,值得在临床进一步研究。

    Abstract:

    【Abstract】 Objective To explore the distribution of thymidylate synthase ( TYMS) gene in advanced triplenegative breast cancer (TNBC) patients and the relationship between the gene expression and the effect of chemotherapy. Methods 97 patients with advanced TNBC were treated with TAC, TP, or TX scheme, and each patient was detected TYMS gene mRNA expression with liquid chip technology, then analyzed the status of TYMS gene expression in TNBC, and the relationship between TYMS gene expression and chemotherapy curative effect. Results TYMS gene mRNA expression in TNBC had no obvious correlation with age, menstrual status, histological grade, transfer parts, Ki67 and PS score, the P value was greater than 005. TYMS gene expression was related with the effect of fluoropyimidine. Lower expression had a good curative effect. The difference was statistically significant. Conclusion TYMS gene might be a predicted genes of chemotherapy curative effect in TNBC. Tt was deserved further research.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2019-01-22
您是第位访问者
网站版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403 本网站支持 IPv6    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司